Genus PLC — Director's Dealing 2019

Mar 4, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7856R

Genus PLC

04 March 2019

4 March 2019

Genus plc

Director/PDMR Shareholding

Genus plc (LSE: GNS) announces that, further to the vesting of contingent rights over ordinary shares in Genus on 5 January 2019 under an individual restricted stock award agreement, Dr. Nate Zwald, a member of the Genus Executive Leadership Team, sold ordinary shares in Genus on 1 March 2019, on the London Stock Exchange to offset income tax and social security liabilities due on the exercise, and retained the balance of ordinary shares.

The below notification made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the number of contingent rights exercised and ordinary shares sold.

For further information please contact:

Genus:

Vaughn Walton, Interim Deputy Company Secretary                                                      Tel: +44 (0)1256 347100

Table A - GELT Restricted Stock Award Exercise

1.   

Details of the person discharging managerial responsibilities / person closely associated

a.            

Name

Dr. Nate Zwald

2.           

Reason for the notification

a.           

Position/status

Chief Operating Officer, Genus ABS Dairy

b.           

Initial notification

/Amendment

Initial notification

3.           

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.           

Name

Genus plc

b.          

LEI

54930022EOITNKSIGH56

4.           

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.           

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

GB0002074580

b.           

Nature of the transaction

Acquisition of shares following exercise of 3,612 contingent rights under an individual restricted stock award agreement.

c.            

Price(s) and volume(s)

Price(s)	Volume(s)
0p	3,612

d.           

Aggregated information

·     Aggregated volume

·     Price

Average price(s)	Total volume(s)
0p	3,612

e.           

Date of the transaction

2019-03-01

f.            

Place of the transaction

Outside a trading venue.

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.   

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

GB0002074580

b.   

b.

Nature of the transaction

Sale of 1,293 shares arising from the exercise of contingent rights under an individual restricted stock award agreement, to offset income tax and social security liabilities due on the exercise.

c.    

c.

Price(s) and volume(s)

Price(s)	Volume(s)
2,198.0404p	1,293

d.   

d.

Aggregated information

·     Aggregated volume

·     Price

Average price(s)	Total volume(s)
2,198.0404p	1,293

e.

Date of the transaction

2019-03-01

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHUSAVRKRAORAR